ArticleScientific reports2026
Explainable AI based ensemble model for the identification of Schizophrenia prodromal phase.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Schizophrenia is a psychotic spectrum disorder, which impacts multiple domains, including cognitive functioning, interpersonal relationships, impairments in daily activities and ultimately reduces the quality of life for affected individuals. As a chronic mental health condition, schizophrenia affects millions of people worldwide and leads to cognitive dysfunctions and abnormal behaviors in patients. In recent decades, Artificial Intelligence (AI) has revolutionized healthcare, by making remarkable contributions towards disease diagnosis, personalized treatment planning, and enhanced patient care outcomes. Therefore, we presented an AI framework using Machine Learning (ML) and Ensemble Learning (EL) models along with Feature Selection to predict prodromal symptoms in Schizophrenia patients. We utilized an Open-source dataset collected from 5000 patients comprising clinical, psychological and behavioral symptoms. Among all the developed classifiers, the customized EL-based STACK models achieved best results for Accuracy, Precision, Recall, F1-score and Average AUC of 96.2%, 96%, 96%, 96.7%, and 93% respectively. Recently, Explainable AI (XAI) techniques are gaining attention in making classifier predictions more interpretable, understandable and reliable. Therefore, we employed XAI-based Shapley Additive exPlanations (SHAP) architecture, for generating visualizations including Violin, Waterfall, Force and Dependence Plots, which deliver meaningful interpretations of proposed classifier predictions. The motivation of this research study is to correctly predict the prodromal symptoms of Schizophrenia disease by employing EL-based stacking classifiers integrated with XAI tools, which can help the clinicians in making informed decisions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.